SEARCH

SEARCH BY CITATION

References

  • Babu GR & Laxminarayan R (2012) The unsurprising story of MDR-TB resistance in India. Tuberculosis (Edinburgh, Scotland) 92, 301306.
  • Daniel OJ & Alausa OK (2006) Treatment outcome of TB/HIV positive and TB/HIV negative patients on directly observed treatment, short course (DOTS) in Sagamu. Nigerian journal of medicine 15, 222226.
  • Errol L, Isaakidis P, Zachariah R et al. (2012) Tracing patients on antiretroviral treatment lost-to-follow-up in an urban slum in India. Journal of Advanced Nursing 68, 23992409.
  • Gebremariam MK, Bjune GA & Frich JC (2010) Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health 10, 651.
  • Gonzalez JS, Batchelder AW & Psaros Safren SA (2011) Depression and HIV/AIDS Treatment Nonadherence: a review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes 2011, 181187.
  • Ingersoll KS & Cohen J (2008) The impact of medication regimen factors on adherence to chronic treatment: a review of literature. Journal of Behavioral Medicine 31, 213224.
  • Isaakidis P, Cox HS, Varghese B et al. (2011) Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India. PLoS ONE 6, e28066.
  • Isaakidis P, Varghese B, Mansoor H et al. (2012) Adverse events among HIV/MDR-TB Co-Infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India. PLoS ONE 7, e40781.
  • Johnston JC, Shahidi NC, Sadatsafavi M & Fitzgerald JM (2009) Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS ONE 4, e6914.
  • Kumarasamy N, Safren SA, Raminani SR et al. (2005) Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care and STDs 19, 526.
  • Mills EJ, Nachega JB, Bangsberg DR et al. (2006) Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS medicine 3, e438.
  • Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A & Volmink J (2007) Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Medicine 4, e238.
  • Ngamvithayapong J, Winkvist A & Diwan V (2000) High AIDS awareness may cause tuberculosis patient delay: results from an HIV epidemic area, Thailand. AIDS 14, 14131419.
  • Orenstein EW, Basu S, Shah NS et al. (2009) Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. The Lancet infectious diseases 9, 153161.
  • RNTCP Annual Status Report (2012) TB Control India.
  • Sagbakken M, Frich JC & Bjune G (2008) Barriers and enablers in the management of tuberculosis treatment in Addis-Ababa, Ethiopia: a qualitative study. BMC Public Health 8, 11.
  • Shargie EB & Lindtjørn B (2007) Determinants of treatment adherence among smear positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Medicine 4, e37.
  • Toczek A, Cox H, Cros PD, Cooke G & Ford N. (2013) Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis. The International Journal of Tuberculosis and Lung Disease 17, 299307.
  • World Health Organization (WHO) (2010) Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Recommendations for a public health approach. 2010 revision. Geneva.
  • World Health Organization (WHO) (2011) Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis, 2011 Update. Geneva.